AU2007219569B2 - Compounds analogous to growth hormone peptide secretagogues and preparations containing them - Google Patents
Compounds analogous to growth hormone peptide secretagogues and preparations containing themInfo
- Publication number
- AU2007219569B2 AU2007219569B2 AU2007219569A AU2007219569A AU2007219569B2 AU 2007219569 B2 AU2007219569 B2 AU 2007219569B2 AU 2007219569 A AU2007219569 A AU 2007219569A AU 2007219569 A AU2007219569 A AU 2007219569A AU 2007219569 B2 AU2007219569 B2 AU 2007219569B2
- Authority
- AU
- Australia
- Prior art keywords
- ghrelin
- ghs
- growth hormone
- receptor
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060050A CU23558A1 (es) | 2006-02-28 | 2006-02-28 | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
| CU2006-0050 | 2006-02-28 | ||
| PCT/CU2007/000007 WO2007098716A1 (es) | 2006-02-28 | 2007-02-28 | Compuestos analogos a los secretagogos peptidicos de la hormona de crecimiento y preparaciones que los contienen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2007219569A1 AU2007219569A1 (en) | 2007-09-07 |
| AU2007219569B2 true AU2007219569B2 (en) | 2012-03-15 |
Family
ID=40130780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007219569A Ceased AU2007219569B2 (en) | 2006-02-28 | 2007-02-28 | Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8367620B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1997827B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5183496B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101409277B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101432294B (cg-RX-API-DMAC7.html) |
| AR (1) | AR059646A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007219569B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0708366A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2637593C (cg-RX-API-DMAC7.html) |
| CL (2) | CL2007000528A1 (cg-RX-API-DMAC7.html) |
| CU (1) | CU23558A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2441441T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008011142A (cg-RX-API-DMAC7.html) |
| MY (1) | MY184130A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20084118L (cg-RX-API-DMAC7.html) |
| RU (1) | RU2416618C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007098716A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200807162B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4831551B2 (ja) * | 2008-11-06 | 2011-12-07 | 国立大学法人名古屋大学 | 非虚血性心筋障害に対する医薬 |
| CU24473B1 (es) * | 2016-11-01 | 2020-02-04 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal |
| RU2734835C1 (ru) * | 2020-02-11 | 2020-10-23 | Федеральное государственное бюджетное учреждение науки Лимнологический институт Сибирского отделение Российской академии наук (ЛИН СО РАН) | Способ повышения жизнестойкости эмбрионов рыб в аквакультуре |
Family Cites Families (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3239345A (en) | 1965-02-15 | 1966-03-08 | Estrogenic compounds and animal growth promoters | |
| US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4036979A (en) | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
| AU628322B2 (en) | 1988-01-28 | 1992-09-17 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| AU637316B2 (en) | 1988-01-28 | 1993-05-27 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| JP2670680B2 (ja) | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
| DK0554381T3 (da) | 1990-10-25 | 1996-04-09 | Genentech Inc | Anvendelse af beskyttende midler mod reaktive oxygenforbindelser |
| US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| CA2147503A1 (en) | 1992-11-06 | 1994-05-26 | Judith M. Pisano | Substituted dipeptide analogs promote release of growth hormone |
| US5726319A (en) | 1992-11-06 | 1998-03-10 | Merck & Co., Inc. | Biphenyl substituted dipeptide analogs promote release of growth hormone |
| US5578593A (en) | 1992-12-11 | 1996-11-26 | Merck & Co., Inc. | Spiro piperidines and homologs promote release of growth hormone |
| SK282166B6 (sk) | 1992-12-11 | 2001-11-06 | Merck & Co., Inc. | Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom |
| AU8083694A (en) | 1993-10-19 | 1995-05-08 | Merck & Co., Inc. | Combination of bisphosphonates and growth hormone secretagogues |
| US5492916A (en) | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| BR9408019A (pt) | 1993-11-09 | 1997-08-26 | Merck & Co Inc | Composto composição util para aumentar a produção endógena ou a liberaçao de hormonio do crescimento em ser humano ou um animal e para o tratamento da osteoporose processos para aumentar os niveis de hormônio do crescimento em um ser humano ou um animal e a eficácia de alimentação promover o crescimento aumentar a produçao de leite e melhorar a qualidade da carcaça de gado para tratar ou previnir uma condição selecionada para tratar osteoporose e para preparar um composto |
| WO1995014666A1 (en) | 1993-11-24 | 1995-06-01 | Merck & Co., Inc. | Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
| US5721251A (en) | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
| US5854211A (en) | 1993-12-23 | 1998-12-29 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| CA2179597A1 (en) | 1993-12-23 | 1995-06-29 | Nils Langeland Johansen | Compounds with growth hormone releasing properties |
| US5721250A (en) | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| US5777112A (en) | 1994-06-13 | 1998-07-07 | Merck & Co., Inc | Piperazine compounds promote release of growth hormone |
| WO1996002530A1 (en) | 1994-07-20 | 1996-02-01 | Merck & Co., Inc. | Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone |
| US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
| WO1996022996A1 (en) | 1995-01-25 | 1996-08-01 | Nippon Chemiphar Co., Ltd. | Dihydrophenazine derivatives |
| MY113488A (en) | 1995-01-27 | 2002-03-30 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| AU4534596A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| AU4534696A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US5559128A (en) | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
| AU5486396A (en) | 1995-04-19 | 1996-11-07 | Merck & Co., Inc. | Process for the preparation of spiroindolines |
| WO1996035713A1 (en) | 1995-05-08 | 1996-11-14 | Pfizer, Inc. | Dipeptides which promote release of growth hormone |
| JP3133073B2 (ja) | 1995-05-29 | 2001-02-05 | ファイザー・インコーポレーテッド | 成長ホルモンの放出を促進するジペプチド類 |
| HUP9802821A3 (en) | 1995-06-22 | 2000-03-28 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| AU6772996A (en) | 1995-08-21 | 1997-03-12 | Eli Lilly And Company | 2-acylaminopropanamides as growth hormone secretagogues |
| WO1997007117A1 (en) | 1995-08-21 | 1997-02-27 | Eli Lilly And Company | 2-acylaminopropanamines as growth hormone secretagogues |
| EP0766966A3 (en) | 1995-09-08 | 2001-02-28 | Eli Lilly And Company | Method of treating insulin resistance |
| AU7169696A (en) | 1995-09-26 | 1997-04-17 | Merck & Co., Inc. | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
| US5723616A (en) | 1995-10-27 | 1998-03-03 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
| US5767124A (en) | 1995-10-27 | 1998-06-16 | Merck & Co., Inc. | Polymorphic forms of a growth hormone secretagogue |
| JPH11513989A (ja) | 1995-10-27 | 1999-11-30 | メルク エンド カンパニー インコーポレーテッド | 成長ホルモン分泌促進薬の湿式造粒製剤 |
| BR9610887A (pt) | 1995-10-27 | 1999-07-13 | Merck & Co Inc | Processo para a preparação de um composto |
| ES2229289T3 (es) | 1995-12-13 | 2005-04-16 | MERCK & CO., INC. | Familia de receptores de secretagogo de la hormona del crecimiento. |
| WO1997022004A1 (en) | 1995-12-13 | 1997-06-19 | Merck & Co., Inc. | Assays for growth hormone secretagogue receptors |
| IT1277113B1 (it) | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
| WO1997022367A1 (en) | 1995-12-20 | 1997-06-26 | Merck & Co., Inc. | Radiolabeled growth hormone secretagogue |
| AU715856B2 (en) | 1995-12-22 | 2000-02-10 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| AU2334097A (en) | 1996-03-21 | 1997-10-10 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
| AU2722297A (en) | 1996-04-03 | 1997-10-22 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
| AU2382097A (en) | 1996-04-19 | 1997-11-12 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US5919777A (en) | 1996-04-24 | 1999-07-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| WO1997040023A1 (en) | 1996-04-24 | 1997-10-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| AU711884B2 (en) | 1996-05-07 | 1999-10-21 | Merck & Co., Inc. | Enhancement of sleep with a growth hormone secretagogue |
| WO1997041878A1 (en) | 1996-05-07 | 1997-11-13 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
| AU2764797A (en) | 1996-05-14 | 1997-12-05 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
| WO1997044042A1 (en) | 1996-05-22 | 1997-11-27 | Arch Development Corporation | Sleep quality improvement using a growth hormone secretagogue |
| JP2000512274A (ja) | 1996-05-31 | 2000-09-19 | ノボ ノルディスク アクティ―ゼルスカブ | 骨粗しょう症の周期的(整合性)治療における成長ホルモン成分及び骨抗吸収剤 |
| EP1184370B1 (en) | 1996-07-22 | 2005-09-14 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| WO1998010653A1 (en) | 1996-09-13 | 1998-03-19 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| WO1998018815A1 (en) | 1996-10-25 | 1998-05-07 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
| SE9703929D0 (sv) | 1996-11-22 | 1997-10-28 | Pharmacia & Upjohn Ab | Therapeutical use and method |
| WO1998046569A1 (fr) | 1997-04-11 | 1998-10-22 | Sumitomo Pharmaceuticals Co., Ltd. | Derives de benzene |
| JP2000514838A (ja) | 1997-05-14 | 2000-11-07 | 藤沢薬品工業株式会社 | 成長ホルモンの放出を促進するピペリジノ誘導体 |
| US5861149A (en) | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
| WO1998058950A1 (en) | 1997-06-20 | 1998-12-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| UA64751C2 (uk) | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
| UA53716C2 (uk) | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
| US6251902B1 (en) | 1997-06-25 | 2001-06-26 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
| ZA987383B (en) | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
| AU758160B2 (en) | 1997-08-22 | 2003-03-20 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives |
| IL137007A0 (en) | 1998-01-16 | 2001-06-14 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| WO1999039730A1 (en) | 1998-02-09 | 1999-08-12 | Kaken Pharmaceutical Co., Ltd. | Oral preparations containing peptides promoting the secretion of growth hormone |
| KR20010041533A (ko) | 1998-03-03 | 2001-05-25 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | (2e)-5-아미노-5-메틸헥스-2-엔오산n-메틸-n-((1r)-1-(n-메틸-n-((1r)-1-(메틸카르바모일)-2-페닐에틸)카르바모일)-2-(2-나프틸)에틸)아미드의신규한 염 형태 |
| CZ301276B6 (cs) | 1998-05-11 | 2009-12-30 | Novo Nordisk A/S | Piperidinový derivát vykazující schopnost uvolnování rustového hormonu |
| WO1999064456A1 (en) | 1998-06-09 | 1999-12-16 | Novo Nordisk A/S | A method for preparing a compound with growth hormone releasing properties |
| AP9901582A0 (en) | 1998-06-16 | 1999-06-30 | Pfizer Prod Inc | Combination therapy for musculoskeletal frailty. |
| AU3342099A (en) | 1998-06-16 | 2000-01-05 | Pfizer Products Inc. | Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| CN1304424C (zh) | 1998-06-30 | 2007-03-14 | 诺沃挪第克公司 | 具有生长激素释放特性的化合物 |
| CN1161333C (zh) | 1998-08-20 | 2004-08-11 | 住友制药株式会社 | 作为生长激素释放剂的2-羟基吲哚衍生物 |
| US6358951B1 (en) | 1998-08-21 | 2002-03-19 | Pfizer Inc. | Growth hormone secretagogues |
| ATE304373T1 (de) * | 1999-12-28 | 2005-09-15 | Kaken Pharma Co Ltd | Nervenschutzmittel |
| CA2411667A1 (en) | 2000-05-30 | 2001-12-06 | Merck & Co. Inc. | Ghrelin analogs |
| ATE446758T1 (de) | 2000-05-31 | 2009-11-15 | Pfizer Prod Inc | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts |
| ATE302181T1 (de) | 2000-06-13 | 2005-09-15 | Zentaris Gmbh | Verbindungen zur stimulation der sekretion von wachstumshormonen |
| AU2001274601A1 (en) | 2000-06-23 | 2002-01-02 | Kaken Pharmaceutical Co., Ltd. | Preventives or remedies for heart failure |
| ITMI20011445A1 (it) | 2001-07-06 | 2003-01-06 | Europ Geie | Analoghi della cortistantina capaci di legarsi selettivamente ai recettori dei secretagoghi dell'ormone della crescita |
| CU23043A1 (es) | 2001-12-20 | 2005-05-20 | Ct Ingenieria Genetica Biotech | Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico. |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| WO2005039625A1 (en) | 2003-10-28 | 2005-05-06 | Rheoscience A/S | Growth hormone secretagogue receptor agonists |
| US7504506B2 (en) | 2003-11-04 | 2009-03-17 | Elixir Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
| WO2005048916A2 (en) | 2003-11-20 | 2005-06-02 | Biovitrum Ab | Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
-
2006
- 2006-02-28 CU CU20060050A patent/CU23558A1/es active IP Right Grant
-
2007
- 2007-02-27 AR ARP070100806A patent/AR059646A1/es not_active Application Discontinuation
- 2007-02-27 CL CL2007000528A patent/CL2007000528A1/es unknown
- 2007-02-28 CA CA2637593A patent/CA2637593C/en not_active Expired - Fee Related
- 2007-02-28 RU RU2008138569/10A patent/RU2416618C2/ru not_active IP Right Cessation
- 2007-02-28 US US12/281,085 patent/US8367620B2/en not_active Expired - Fee Related
- 2007-02-28 MY MYPI20083178A patent/MY184130A/en unknown
- 2007-02-28 EP EP07711101.1A patent/EP1997827B1/en not_active Not-in-force
- 2007-02-28 WO PCT/CU2007/000007 patent/WO2007098716A1/es not_active Ceased
- 2007-02-28 KR KR1020087023543A patent/KR101409277B1/ko not_active Expired - Fee Related
- 2007-02-28 BR BRPI0708366-1A patent/BRPI0708366A2/pt not_active IP Right Cessation
- 2007-02-28 CN CN2007800153594A patent/CN101432294B/zh not_active Expired - Fee Related
- 2007-02-28 ES ES07711101.1T patent/ES2441441T3/es active Active
- 2007-02-28 MX MX2008011142A patent/MX2008011142A/es active IP Right Grant
- 2007-02-28 JP JP2008556643A patent/JP5183496B2/ja not_active Expired - Fee Related
- 2007-02-28 AU AU2007219569A patent/AU2007219569B2/en not_active Ceased
-
2008
- 2008-08-19 ZA ZA200807162A patent/ZA200807162B/xx unknown
- 2008-09-29 NO NO20084118A patent/NO20084118L/no not_active Application Discontinuation
-
2016
- 2016-06-24 CL CL2016001648A patent/CL2016001648A1/es unknown
Non-Patent Citations (2)
| Title |
|---|
| CORT JH et al: "Regional and systemic haemodynamic effects of some vasopressins", EUROP. J. CLIN. INVEST, vol. 5, 1975, pages 165-175 * |
| LAMMEK B et al: "Synthesis of three 1-9 NH2-terminallyextended arginine vasopressins with prolonged biological activities", EXPERENTIA, vol. 43, 1987, pages 1211-1212 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008011142A (es) | 2008-09-08 |
| CN101432294B (zh) | 2013-09-11 |
| EP1997827A1 (en) | 2008-12-03 |
| JP5183496B2 (ja) | 2013-04-17 |
| WO2007098716A8 (es) | 2008-12-18 |
| CU23558A1 (es) | 2010-07-20 |
| ES2441441T3 (es) | 2014-02-04 |
| JP2009528303A (ja) | 2009-08-06 |
| RU2008138569A (ru) | 2010-04-10 |
| US8367620B2 (en) | 2013-02-05 |
| MY184130A (en) | 2021-03-19 |
| ZA200807162B (en) | 2009-06-24 |
| CN101432294A (zh) | 2009-05-13 |
| KR101409277B1 (ko) | 2014-06-24 |
| NO20084118L (no) | 2008-09-29 |
| US20100055118A1 (en) | 2010-03-04 |
| RU2416618C2 (ru) | 2011-04-20 |
| CA2637593C (en) | 2015-04-14 |
| CL2007000528A1 (es) | 2008-01-18 |
| CA2637593A1 (en) | 2007-09-07 |
| BRPI0708366A2 (pt) | 2011-05-24 |
| WO2007098716A1 (es) | 2007-09-07 |
| CL2016001648A1 (es) | 2017-02-24 |
| EP1997827B1 (en) | 2013-10-09 |
| AU2007219569A1 (en) | 2007-09-07 |
| AR059646A1 (es) | 2008-04-16 |
| KR20080110763A (ko) | 2008-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kaiya et al. | Identification of tilapia ghrelin and its effects on growth hormone and prolactin release in the tilapia, Oreochromis mossambicus | |
| Chan et al. | Identification and functional characterization of two alternatively spliced growth hormone secretagogue receptor transcripts from the pituitary of black seabream Acanthopagrus schlegeli | |
| Kaiya et al. | Amidated fish ghrelin: purification, cDNA cloning in the Japanese eel and its biological activity | |
| Muccioli et al. | Heterogeneity of ghrelin/growth hormone secretagogue receptors: toward the understanding of the molecular identity of novel ghrelin/GHS receptors | |
| Bednarek et al. | Structure− function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a | |
| Kaiya et al. | Chicken ghrelin: purification, cDNA cloning, and biological activity | |
| Spindel | Mammalian bombesin-like peptides | |
| Smith | Development of growth hormone secretagogues | |
| EP1729792B1 (en) | Y4 selective receptor agonist for therapeutic interventions | |
| Miura et al. | Purification and properties of ghrelin from the intestine of the goldfish, Carassius auratus | |
| US20060084597A2 (en) | Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity | |
| Ringuet et al. | G protein‐coupled receptor interactions and modification of signalling involving the ghrelin receptor, GHSR1a | |
| ZA200705031B (en) | Y4 selective receptor agonists for therapeutic interventions | |
| Sze et al. | Pituitary adenylate cyclase-activating polypeptide (PACAP) as a growth hormone (GH)-releasing factor in grass carp: II. Solution structure of a brain-specific PACAP by nuclear magnetic resonance spectroscopy and functional studies on GH release and gene expression | |
| Vodnik et al. | Ghrelin receptor ligands reaching clinical trials: from peptides to peptidomimetics; from agonists to antagonists | |
| EP1807099A2 (en) | Y2 selective receptor agonists for therapeutic interventions | |
| CN106661088B (zh) | 鱼类繁殖中的神经激肽b拮抗剂 | |
| Eliakim et al. | Exercise, training, and the GH-IGF-I axis | |
| CA2637593C (en) | Compounds analogous to growth hormone peptide secretagogues and preparations containing them | |
| Smith et al. | Growth hormone secretagogues: prospects and potential pitfalls | |
| Gelato | Growth hormone-releasing hormone: clinical perspectives | |
| Reeve Jr et al. | Synthesis of biologically active canine CCK-58 | |
| Muccioli et al. | Known and unknown growth hormone secretagogue receptors and their ligands | |
| Frühbeck et al. | Age-related differences in the thermogenic and ponderal effects following the administration of fragment peptides from the rat ob protein | |
| Kojima et al. | Discovery of Ghrelin, an Endogenous Ligand for the Growth-Hormone Secret Agogue Receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |